Innovaderma PLC (LON:IDP) shares traded up 8.5% during trading on Friday . The stock traded as high as GBX 116.86 ($1.53) and last traded at GBX 114.50 ($1.50). 250,155 shares were traded during trading, an increase of 207% from the average session volume of 81,503 shares. The stock had previously closed at GBX 105.50 ($1.38).
Separately, FinnCap reissued a “corporate” rating on shares of Innovaderma in a report on Thursday, February 21st.
The firm has a market cap of $16.24 million and a P/E ratio of 124.44. The company has a debt-to-equity ratio of -0.01, a quick ratio of 0.99 and a current ratio of 2.32.
In related news, insider Joe Bayer acquired 5,000 shares of the company’s stock in a transaction on Tuesday, February 26th. The stock was acquired at an average price of GBX 86 ($1.12) per share, with a total value of £4,300 ($5,618.71).
ILLEGAL ACTIVITY WARNING: This report was published by Ticker Report and is owned by of Ticker Report. If you are reading this report on another publication, it was illegally copied and republished in violation of United States and international trademark & copyright legislation. The legal version of this report can be viewed at https://www.tickerreport.com/banking-finance/4244518/innovaderma-idp-trading-8-5-higher.html.
Innovaderma Company Profile (LON:IDP)
InnovaDerma PLC, through its subsidiaries, engages in the research, manufacture, and marketing of clinically proven products in life sciences, beauty, and personal care products in the United Kingdom, Europe, the United States, Australasia, North Asia, and Africa. The company offers a range of men's skincare products, including hand and body washes, hand creams, face washes, and face moisturizers under the Charles + Lee brand name; and shampoos, conditioners, and laser technology treatments to treat male and female hair loss, alopecia, and thinning hair under the Leimo brand name.
Featured Article: How is a Moving Average Calculated?
Receive News & Ratings for Innovaderma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovaderma and related companies with MarketBeat.com's FREE daily email newsletter.